An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer

Veronica Ruta, Chiara Naro, Marco Pieraccioli, Adriana Leccese, Livia Archibugi, Eleonora Cesari, Valentina Panzeri, Chantal Allgöwer, Paolo Giorgio Arcidiacono, Massimo Falconi, Carmine Carbone, Giampaolo Tortora, Federica Borrelli De Andreis, Fabia Attili, Cristiano Spada, Giuseppe Quero, Sergio Alfieri, Claudio Doglioni, Alexander Kleger, Gabriele CapursoClaudio Sette*

*Corresponding author

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)101411-101433
Number of pages23
JournalCell Reports Medicine
Volume5
DOIs
Publication statusPublished - 2024

Keywords

  • RNA processing
  • alternative splicing
  • chemoresistance

Cite this